| Literature DB >> 30153282 |
Nicole E Blackburn1,2, Joseph G Mc Veigh3, Eilis M Mc Caughan4, Richard D Kennedy5, Stuart A McIntosh5, Iseult M Wilson6.
Abstract
INTRODUCTION: Current evidence suggests that patients who have latissimus dorsi (LD) breast reconstruction following mastectomy for breast cancer can experience long-term shoulder dysfunction. However, as there is no standardised assessment or follow-up period within the literature, findings are conflicting. This research aimed to investigate the impact on daily living of immediate and delayed LD breast reconstruction in women following mastectomy for breast cancer.Entities:
Mesh:
Year: 2018 PMID: 30153282 PMCID: PMC6112655 DOI: 10.1371/journal.pone.0202859
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of women (n = 15).
| Characteristic | Number | % |
|---|---|---|
| Mean (SD) | 56 (7.5) | |
| Range | 45–71 | |
| Immediate | 12 | 80 |
| Delayed | 3 | 20 |
| LD | 4 | 27 |
| LD + Implant | 11 | 73 |
| Dominant | 6 | 40 |
| Non-Dominant | 9 | 60 |
| Time since Reconstruction (months) | ||
| Mean (SD) | 62 (28.9) | |
| Range | 12–122 |
Survey respondents demographic and medical information.
| Demographic and Medical Information (n = 159) | N | % |
|---|---|---|
| Stage 0 | 11 | 7.5 |
| Stage I | 7 | 4.8 |
| Stage II | 46 | 31.5 |
| Stage III | 36 | 24.7 |
| Stage IV | 4 | 2.7 |
| Don’t Know | 42 | 28.8 |
| Chemotherapy | 106 | 66.7 |
| Radiotherapy | 83 | 52.2 |
| Hormone Replacement Therapy | 20 | 12.6 |
| Targeted Biological Therapy | 20 | 12.6 |
| Hormone Therapy | 11 | 6.9 |
| Hormone Therapy | 61 | 82.4 |
| Chemotherapy | 6 | 8.1 |
| Biological Targeted Therapy | 5 | 6.8 |
| Radiotherapy | 2 | 2.7 |
| Yes | 26 | 16.4 |
| No | 132 | 83 |
| Don’t Know | 1 | 0.6 |
| Full-Time Paid Employment | 92 | 59 |
| Part-Time Paid Employment | 28 | 17.6 |
| Housewife | 17 | 10.7 |
| Self-Employed | 8 | 5 |
| Unemployed | 5 | 3.1 |
| Part-time Unpaid Employment/Volunteer | 3 | 1.9 |
| Active Retired | 2 | 1.3 |
| Retired for Medical Reasons | 1 | 0.6 |
Questionnaire survey (n = 159): non-validated outcome measures.
| Functional activities ‘before’ compared with ‘today’ | N | Sig. |
|---|---|---|
| Reaching up to a high shelf | 153 | 0.000 |
| Dressing activities behind your back | 154 | 0.004 |
| Pushing down with your arm | 155 | 0.001 |
| Opening a tight jar | 154 | 0.000 |
*Paired samples t-test
Questionnaire survey (n = 159): Validated outcome measure scores.
| Outcome Measure | Mean (SD) | Possible Range | Effect |
|---|---|---|---|
| FABQ Physical Activity Subscale | 11.0 (± 7.3) | 0–24 | Low |
| FABQ Work Subscale | 8.4 (± 10.1) | 0–42 | Low |
| EuroQol Mobility | 1.8 (± 0.96) | 1–5 | None—Slight |
| EuroQol Self-Care | 1.7 (± 0.92) | 1–5 | None—Slight |
| EuroQol Usual Activities | 2.2 (± 1.1) | 1–5 | Slight—Moderate |
| EuroQol Pain/Discomfort | 2.5 (± 1.0) | 1–5 | Slight—Moderate |
| EuroQol Anxiety/Depression | 2.0 (± 1.1) | 1–5 | Slight—Moderate |
| BPI Severity | 3.4 (± 2.3) | 0–10 | Mild—Moderate |
| BPI Interference | 3.5 (± 2.9) | 0–10 | Mild—Moderate |
| DASH | 29.0 (± 23.9) | 0–100 | Moderate |
| SLDS-BC | 79.9 (± 32.5) | 27–189 | Moderate |
Subgroup analysis*: Node removal.
| Node Removal | Statistics | |||||
|---|---|---|---|---|---|---|
| N (Yes) | N (No) | U | z | p | r | |
| DASH | 123 | 20 | 870.5 | -2.09 | 0.04 | 0.18 |
| FAQQ PA Subscale | 118 | 18 | 760.5 | -1.94 | 0.05 | -0.17 |
| FABQ Work Subscale | 113 | 17 | 729.5 | -1.64 | 0.10 | -0.14 |
| BPI Interference | 118 | 17 | 757.5 | -1.63 | 0.10 | -0.14 |
| SLDSBC | 128 | 20 | 1179.5 | -0.57 | 0.58 | -0.05 |
| EuroQol Mobility | 127 | 21 | 896.5 | -2.66 | 0.01 | 0.218 |
| EuroQol Self-Care | 127 | 21 | 987.5 | -2.17 | 0.03 | 0.179 |
| EuroQol Usual Activities | 127 | 21 | 1237 | -0.56 | 0.58 | -0.05 |
| EuroQol Pain/Discomfort | 127 | 20 | 1046 | -1.32 | 0.19 | -0.11 |
| EuroQol Anxiety/Depression | 127 | 21 | 1072 | -1.52 | 0.13 | -0.13 |
| EuroQol VAS (O-100) | 125 | 21 | 1161.5 | -0.84 | 0.40 | -0.07 |
*Mann-Whitney U Test
Characteristics of women (n = 4).
| Characteristic | Number | % |
|---|---|---|
| Mean (SD) | 36.8 (13.4) | |
| Range | 24–58 | |
| Immediate | 2 | 50 |
| Delayed | 2 | 50 |
| LD | 3 | 75 |
| LD + Implant | 1 | 25 |
| Dominant | 2 | 50 |
| Non-Dominant | 2 | 50 |
| Mean (SD) | 39.8 (34.6) | |
| Range | 9–90 |